Portal de Periódicos da CAPES

Cost of Parkinson's disease in Europe

2005; Wiley; Volume: 12; Issue: s1 Linguagem: Inglês

10.1111/j.1468-1331.2005.01197.x

1468-1331

Peter Lindgren, Sonja von Campenhausen, EA Spottke, Uwe Siebert, Richard Dodel,

Neurological disorders and treatments

European Journal of NeurologyVolume 12, Issue s1 p. 68-73 Cost of Parkinson's disease in Europe P Lindgren, P Lindgren Stockholm Health Economics, Stockholm, Sweden and Department of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, SwedenSearch for more papers by this authorS Von Campenhausen, S Von Campenhausen Department of Neurology, Friedrich-Wilhelms-University Bonn, GermanySearch for more papers by this authorEa Spottke, Ea Spottke Department of Neurology, Friedrich-Wilhelms-University Bonn, GermanySearch for more papers by this authorU Siebert, U Siebert Institute for Technology Assessment and Department of Radiology, Massachussetts General Hospital, Harvard Medical School, Boston, USASearch for more papers by this authorR Dodel, R Dodel Department of Neurology, Friedrich-Wilhelms-University Bonn, GermanySearch for more papers by this author P Lindgren, P Lindgren Stockholm Health Economics, Stockholm, Sweden and Department of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, SwedenSearch for more papers by this authorS Von Campenhausen, S Von Campenhausen Department of Neurology, Friedrich-Wilhelms-University Bonn, GermanySearch for more papers by this authorEa Spottke, Ea Spottke Department of Neurology, Friedrich-Wilhelms-University Bonn, GermanySearch for more papers by this authorU Siebert, U Siebert Institute for Technology Assessment and Department of Radiology, Massachussetts General Hospital, Harvard Medical School, Boston, USASearch for more papers by this authorR Dodel, R Dodel Department of Neurology, Friedrich-Wilhelms-University Bonn, GermanySearch for more papers by this author First published: 05 May 2005 https://doi.org/10.1111/j.1468-1331.2005.01197.xCitations: 46 P. Lindgren, Stockholm Health Economics, Stockholm, Sweden and Department of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Anderson DW (1998). Case ascertainment uncertainities in prevalence surveys of Parkinson's disease. Mov Disord 13: 626–632. 10.1002/mds.870130403 CASPubMedWeb of Science®Google Scholar Benito-Léon J (2003). Prevalence of PD and other types of Parkinsonism in three elderly populations of central Spain. Mov Disord 18: 267–274.DOI: 10.1002/mds.10362 10.1002/mds.10362 PubMedWeb of Science®Google Scholar Bergareche A, De La Puente E, Lopez de Munain A et al. (2004). Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain. J Neurol 251: 340–345. 10.1007/s00415-004-0333-3 CASPubMedWeb of Science®Google Scholar Bermejo F, Gabriel R, Vega S, Morales JM, Rocca WA, Anderson DW (2001). Problems and issues with door-to-door, two-phase surveys: an illustration from central Spain. Neuroepidemiology 20: 225–231. 10.1159/000054794 CASPubMedWeb of Science®Google Scholar Campenhausen VS, Bornschein B, Wick R, et al. (2005). Prevalence and incidence of Parkinson's disease in Europe. J. Neuopsychopharmacology, in press. Google Scholar Chio A, Magnani C, Schiffer D (1998). Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 13: 400–405. 10.1002/mds.870130305 CASPubMedWeb of Science®Google Scholar Claveria LE, Duarte J, Sevillano MD et al. (2002). Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey. Mov Disord 17: 242–249.DOI: 10.1002/mds.10087 10.1002/mds.10087 PubMedWeb of Science®Google Scholar D'Alessandro R, Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli D (1987). Prevalence of Parkinson's disease in the Republic of San Marino. Neurology 37: 1679–1682. 10.1212/WNL.37.10.1679 CASPubMedWeb of Science®Google Scholar Dias JA, Felgueiras MM, Sanchez JP, Goncalves JM, Falcao JM, Pimenta ZP (1994). The prevalence of Parkinson's disease in Portugal. A population approach. Eur J Epidemiol 10: 763–767. 10.1007/BF01719295 CASPubMedWeb of Science®Google Scholar Errea J (1997). Prevalence of Parkinson's disease in the Bajo Aragon district. Spain J Neurol Sci 150. Google Scholar Evers S, Obladen M (1994). Epidemiology and therapy of Parkinson disease in inpatient nursing homes. Z Gerontol 27: 270–275. CASPubMedWeb of Science®Google Scholar Fall PA, Axelson O, Fredriksson M et al. (1996). Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol 49: 637–641.DOI: 10.1016/0895-4356(96)00003-0 10.1016/0895-4356(96)00003-0 PubMedWeb of Science®Google Scholar Findley L, Aujla M, Bain PG et al. (2003). Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 18: 1139–1145.DOI: 10.1002/mds.10507 10.1002/mds.10507 CASPubMedWeb of Science®Google Scholar Granieri E, Carreras M, Casetta I et al. (1991). Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol 48: 854–857. 10.1001/archneur.1991.00530200096026 CASPubMedWeb of Science®Google Scholar Hagell P, Nordling S, Reimer J, Grabowski M, Persson U (2002). Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Mov Disord 17: 1213–1220.DOI: 10.1002/mds.10262 10.1002/mds.10262 CASPubMedWeb of Science®Google Scholar Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992). What features improved the accuracy of clinical diagnosis in Parkinson's disease. Neurology 42: 1142–1146. 10.1212/WNL.42.6.1142 CASPubMedWeb of Science®Google Scholar Keranen T, Kaakkola S, Sotaniemi K et al. (2003). Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord 9: 163–168.DOI: 10.1016/S1353-8020(02)00097-4 10.1016/S1353-8020(02)00097-4 CASPubMedWeb of Science®Google Scholar Kis B, Schrag A, Ben-Shlomo Y et al. (2002). Novel three-stage ascertainment method: prevalence of PD and parkinsonism in South Tyrol. Italy Neurol 58: 1820–1825. 10.1212/WNL.58.12.1820 CASPubMedWeb of Science®Google Scholar LePen C, Wait S, Moutard-Martin F, Dujardin M, Ziegler M (1999). Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics 16: 59–69. 10.2165/00019053-199916010-00006 CASPubMedWeb of Science®Google Scholar Lindgren P (2004). Economic evidence in Parkinson's Disease: a review. Eur J Health Econ 5: 63–66.DOI: 10.1007/s10198-005-0290-5 10.1007/s10198-005-0290-5 PubMedGoogle Scholar Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK (1986). Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 292: 534–536. 10.1136/bmj.292.6519.534 CASPubMedWeb of Science®Google Scholar Oertel WH, Quinn NP, Diener, HC, Caplan, LR, Kennard, C, Dichgans J eds (2003). Neurological Disorders: Course and Treatment. San Diego: Academic Press, pp. 715–772. Google Scholar De Rijk MC, Breteler MM, Graveland GA et al. (1995). Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 45: 2143–2146. 10.1212/WNL.45.12.2143 CASPubMedWeb of Science®Google Scholar De Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM (1997). A population perspective on diagnostic criteria for Parkinson's disease. Neurology 48: 1277–1281. 10.1212/WNL.48.5.1277 CASPubMedWeb of Science®Google Scholar Rosati G, Granieri E, Pinna L, Devoto MC (1979). The frequency of Parkinson's disease in the Province of Nuoro (Sardinia). Acta Neurol (Napoli) 1: 303–308. CASPubMedGoogle Scholar Rosati G, Granieri E, Pinna L et al. (1980). The risk of Parkinson disease in Mediterranean people. Neurology 30: 250–255. 10.1212/WNL.30.3.250 CASPubMedWeb of Science®Google Scholar Schrag A, Ben-Shlomo Y, Quinn NP (2000). Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 321: 21–22. 10.1136/bmj.321.7252.21 CASPubMedWeb of Science®Google Scholar Spottke AE, Reuther M, Peter HV et al. (2005). Healthcare utilization and cost of care of patients with Parkinson's disease in Germany. Pharmacoeconomics in press. PubMedWeb of Science®Google Scholar Stroup DF, Berlin JA, Morton SC et al. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Anal Observational Studies Epidemiol (MOOSE) Group. JAMA 283: 2008–2012.DOI: 10.1001/jama.283.15.2008 10.1001/jama.283.15.2008 CASPubMedWeb of Science®Google Scholar Sutcliffe RL, Prior R, Mawby B, McQuillan WJ (1985). Parkinson's disease in the district of the Northampton Health Authority, United Kingdom. A study of prevalence and disability. Acta Neurol Scand 72: 363–379. 10.1111/j.1600-0404.1985.tb00886.x CASPubMedWeb of Science®Google Scholar Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P (1994). Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 90: 111–115. 10.1111/j.1600-0404.1994.tb02689.x CASPubMedWeb of Science®Google Scholar Twelves D, Perkins KS, Counsell C (2003). Systematic review of incidence studies of Parkinson's disease. Mov Disord 18: 19–31.DOI: 10.1002/mds.10305 10.1002/mds.10305 CASPubMedWeb of Science®Google Scholar Van De Vijver DA, Roos RA, Jansen PA, Porsius AJ, De Boer A (2001). Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records. Pharmacoepidemiol Drug Saf 10: 549–554.DOI: 10.1002/pds.624 10.1002/pds.624 CASPubMedWeb of Science®Google Scholar Citing Literature Volume12, Issues1June 2005Pages 68-73 ReferencesRelatedInformation